Vitamin D Analog in Vitamin D 24-hydroxylase Deficiency

Recruiting now · Not applicable

Conditions studied: Idiopathic Infantile Hypercalcemia - Severe Form

In brief

Preclinical evaluation of a vitamin D analog for the treatment of vitamin D 24-hydroxylase using fibroblast from patients with CYP24A1 mutation.

Key facts

Study ID

NCT04987073

Run by

University Hospital, Caen

People needed

30

Starts

2022-07-17

Expected to finish

2027-07-01

Last updated by the study team

2025-07-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• biallelic mutation in CYP24A1
• consent

You may not qualify if…

• none

Where it is running

• Arnaud Molin — Caen, Normandy, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.